Syros Pharmaceuticals, Inc. Human Resources Contracts & Agreements
14 Contracts & Agreements
- Bonus & Incentive Agreements (8 contracts)
- Compensation Agreements (2)
- Consulting Agreements (2)
- Retirement Agreements (1)
- Separation Agreements (1)
- Amended and Restated Director Compensation Policy (Filed With SEC on May 14, 2024)
- Separation Agreement, dated October 16, 2023, by and between the Registrant and Eric. R. Olson, Ph.D (Filed With SEC on March 27, 2024)
- Retirement and Transition Agreement, dated September 28, 2023, by and between the Registrant and Nancy Simonian, M.D (Filed With SEC on November 14, 2023)
- Syros Pharmaceuticals, Inc. Amended and Restated Director Compensation Policy (Filed With SEC on November 14, 2022)
- Form of Restricted Stock Agreement Under 2022 Equity Incentive Plan (Filed With SEC on November 14, 2022)
- Form of Restricted Stock Unit Agreement Under 2022 Equity Incentive Plan (Filed With SEC on November 14, 2022)
- Form of Stock Option Agreement Under 2022 Equity Incentive Plan (Filed With SEC on November 14, 2022)
- Form of Syros Pharmaceuticals, Inc. 2022 Equity Incentive Plan (Filed With SEC on July 18, 2022)
- Form of Restricted Stock Unit Agreement under 2022 Inducement Stock Incentive Plan (Filed With SEC on March 15, 2022)
- Form of Nonstatutory Stock Option Agreement under 2022 Inducement Stock Incentive Pla (Filed With SEC on March 15, 2022)
- 2022 Inducement Stock Incentive Plan (Filed With SEC on March 15, 2022)
- Consulting Agreement dated August 8, 2012 between the Registrant and Richard A. Young, Ph.D., as amended (Filed With SEC on November 12, 2019)
- Form of Restricted Stock Unit Agreement under 2016 Stock Incentive Plan (Filed With SEC on March 7, 2019)
- CONSULTING AGREEMENT (Filed With SEC on March 20, 2017)
